1. Cancer immunotherapy: an evolving paradigm

   • Aifu Lin

   Editorial 17 October 2022 Pages: 791 - 792

2. Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches

   • Tianning Gu
   • Meng Zhu
   • Yongxian Hu

   Review 17 October 2022 Pages: 793 - 811

3. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes

   • Jing Chen
   • Jian Chen
   • Lie Wang

   Review 17 October 2022 Pages: 812 - 822

4. Tumor immune checkpoints and their associated inhibitors

   • Zerui Gao
   • Xingyi Ling
   • Aifu Lin

   Review 17 October 2022 Pages: 823 - 843

5. Iron metabolism, ferroptosis, and lncRNA in cancer: knowns and unknowns

   • Lei Qu
   • Xinyu He
   • Aifu Lin

   Review 17 October 2022 Pages: 844 - 862

6. UPF1 increases amino acid levels and promotes cell proliferation in lung adenocarcinoma via the eIF2α-ATF4 axis

   • Lei Fang
   • Huan Qi
   • Chundong Gu

   Research Article 17 October 2022 Pages: 863 - 875

7. Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy

   • Delin Kong
   • Tingting Yang
   • Yongxian Hu

   Correspondence 17 October 2022 Pages: 876 - 880